PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 46 filers reported holding PSYCHEMEDICS CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,086 | -14.4% | 273,663 | -1.5% | 0.00% | 0.0% |
Q2 2023 | $1,268 | -14.2% | 277,963 | -1.2% | 0.00% | 0.0% |
Q1 2023 | $1,477 | +3.6% | 281,263 | -3.2% | 0.00% | 0.0% |
Q4 2022 | $1,425 | -99.9% | 290,463 | -5.1% | 0.00% | -33.3% |
Q3 2022 | $1,975,000 | -4.5% | 306,163 | -6.1% | 0.00% | +50.0% |
Q2 2022 | $2,068,000 | -12.2% | 326,167 | -4.5% | 0.00% | -33.3% |
Q1 2022 | $2,356,000 | -9.8% | 341,422 | -8.3% | 0.00% | 0.0% |
Q4 2021 | $2,612,000 | -16.7% | 372,146 | -0.3% | 0.00% | -25.0% |
Q3 2021 | $3,137,000 | +17.3% | 373,440 | -2.8% | 0.00% | +33.3% |
Q2 2021 | $2,675,000 | +4.3% | 384,340 | -7.1% | 0.00% | 0.0% |
Q1 2021 | $2,565,000 | +10.8% | 413,660 | -9.0% | 0.00% | 0.0% |
Q4 2020 | $2,314,000 | +15.4% | 454,640 | -0.0% | 0.00% | +50.0% |
Q3 2020 | $2,005,000 | -22.9% | 454,740 | -2.9% | 0.00% | 0.0% |
Q2 2020 | $2,600,000 | -3.1% | 468,454 | +5.6% | 0.00% | -33.3% |
Q1 2020 | $2,684,000 | -38.3% | 443,638 | -6.6% | 0.00% | 0.0% |
Q4 2019 | $4,348,000 | +5.4% | 475,177 | +4.9% | 0.00% | 0.0% |
Q3 2019 | $4,126,000 | -3.1% | 452,866 | +7.4% | 0.00% | -25.0% |
Q2 2019 | $4,256,000 | -27.6% | 421,771 | +0.6% | 0.00% | -20.0% |
Q1 2019 | $5,880,000 | -15.6% | 419,137 | -4.5% | 0.01% | -37.5% |
Q4 2018 | $6,967,000 | -20.9% | 439,000 | -6.2% | 0.01% | -11.1% |
Q3 2018 | $8,804,000 | -51.8% | 468,066 | -48.0% | 0.01% | -10.0% |
Q2 2018 | $18,260,000 | +90.0% | 899,500 | +100.0% | 0.01% | -9.1% |
Q1 2018 | $9,608,000 | +0.6% | 449,800 | -3.1% | 0.01% | 0.0% |
Q4 2017 | $9,549,000 | +5.5% | 464,429 | -5.4% | 0.01% | 0.0% |
Q3 2017 | $9,049,000 | -20.6% | 491,000 | +7.6% | 0.01% | -26.7% |
Q2 2017 | $11,390,000 | +21.5% | 456,500 | -2.3% | 0.02% | +15.4% |
Q1 2017 | $9,371,000 | -24.1% | 467,400 | -6.5% | 0.01% | -35.0% |
Q4 2016 | $12,340,000 | +43.2% | 499,990 | +15.0% | 0.02% | +33.3% |
Q3 2016 | $8,616,000 | +54.0% | 434,700 | +6.8% | 0.02% | +36.4% |
Q2 2016 | $5,594,000 | -0.9% | 407,100 | -0.8% | 0.01% | 0.0% |
Q1 2016 | $5,643,000 | +27.7% | 410,400 | -5.8% | 0.01% | +10.0% |
Q4 2015 | $4,420,000 | -0.5% | 435,900 | -1.4% | 0.01% | -9.1% |
Q3 2015 | $4,443,000 | -30.4% | 442,069 | +2.6% | 0.01% | -26.7% |
Q2 2015 | $6,387,000 | -10.5% | 430,700 | +0.1% | 0.02% | 0.0% |
Q1 2015 | $7,139,000 | +8.3% | 430,300 | -1.1% | 0.02% | -6.2% |
Q4 2014 | $6,589,000 | +6.9% | 434,900 | -0.1% | 0.02% | -5.9% |
Q3 2014 | $6,162,000 | -1.0% | 435,200 | -1.0% | 0.02% | +13.3% |
Q2 2014 | $6,225,000 | -13.9% | 439,600 | +4.1% | 0.02% | -11.8% |
Q1 2014 | $7,231,000 | +22.1% | 422,100 | +4.7% | 0.02% | +21.4% |
Q4 2013 | $5,923,000 | +19.5% | 403,200 | +7.8% | 0.01% | +16.7% |
Q3 2013 | $4,956,000 | +34.3% | 374,000 | +8.9% | 0.01% | +20.0% |
Q2 2013 | $3,689,000 | – | 343,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
Cannell Capital | 78,306 | $540,000 | 0.08% |
RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |